QR Pharma presents New Data on Posiphen in Alzheimer Disease at the 13th AD/PD International Conference
QR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s (AD), Parkinson’s (PD) and other neurodegenerative...
FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that the US FDA has...
Liquid Learning presents the Women in Pharma and Medical Leadership Summit 2017 to be held in Auckland on the 21st-23rd of March.
Liquid Learning is delighted to present the Women in Pharma and Medical Leadership Summit. A unique platform in New Zealand for professional development and...
Epinomics to Collaborate with the Parker Institute for Cancer Immunotherapy at Stanford University
Researchers from Epinomics will collaborate with the research team led by Crystal Mackall, MD, director of the Parker Institute for Cancer Immunotherapy at Stanford,...
Zimmer Biomet Announces FDA Approval of Gel-One Cross-Linked Hyaluronate
Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare announced that the U.S. FDA approved an expanded 26-week efficacy claim for its...
Live broadcast of session on biosimilars and EU regulation: still time to join us!
On February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role of the European Pharmacopoeia...
AMRA announces $9 million investment from Pfizer Venture Investments, Novo Seeds and Industrifonden
Swedish-based digital health company AMRA has announced a $9 million funding round co-led by US-based Pfizer Venture Investments and leading Nordic VC Novo Seeds....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...